CXCR5 and myelodysplastic syndrome: The proportion of CD4+CXCR5+ cells in peripheral blood was significantly increased in MDS patients with AI (19.02 ± 3.23%) than in MDS patients without AI (13.46 ± 3.32%) (P < 0.05).